Myostatin activation in patients with advanced heart failure and after mechanical unloading. - Wikidata - wikimedia - TriplyDB

Myostatin activation in patients with advanced heart failure and after mechanical unloading.

Myostatin activation in patients with advanced heart failure and after mechanical unloading.

http://www.wikidata.org/entity/Q33803837

about

Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting Cardiac cachexia: hic et nunc Satellite cells in human skeletal muscle plasticity Pitx2c is reactivated in the failing myocardium and stimulates myf5 expression in cultured cardiomyocytes Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model.Myostatin is elevated in congenital heart disease and after mechanical unloading Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation Muscle wasting and cachexia in heart failure: mechanisms and therapies.Heart over mind: metabolic control of white adipose tissue and liver Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study.Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients.Treating cancer cachexia to treat cancer The role of myostatin in muscle wasting: an overview Targeting the myostatin signaling pathway to treat muscle wasting diseases Higher Plasma Myostatin Levels in Cor Pulmonale Secondary to Chronic Obstructive Pulmonary Disease.Association of handgrip strength with chronic diseases and multimorbidity: a cross-sectional study Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers.Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy.Myostatin regulates tissue potency and cardiac calcium-handling proteins.Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats.Metabolic and structural impairment of skeletal muscle in heart failure.Skeletal muscle protein metabolism in human heart failure.New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.Skeletal Muscle Changes in Chronic Cardiac Disease and Failure.Muscle wasting is associated with reduced exercise capacity and advanced disease in patients with chronic heart failure.The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy.Myostatin promotes distinct responses on protein metabolism of skeletal and cardiac muscle fibers of rodents.Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.CREB, NF-Y and MEIS1 conserved binding sites are essential to balance Myostatin promoter/enhancer activity during early myogenesis.miR-422a suppresses SMAD4 protein expression and promotes resistance to muscle loss.Metabolic Changes During Cancer Cachexia Pathogenesis.Plasma myostatin levels are related to the extent of right ventricular dysfunction in exacerbation of chronic obstructive pulmonary disease.Increased plasma myostatin in heart failure.Myostatin induces interstitial fibrosis in the heart via TAK1 and p38.Brown Adipose Tissue Controls Skeletal Muscle Function via the Secretion of Myostatin Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases

P2860

Q24609841-28E7CBF7-7025-418C-A015-12145244CF04 Q26744140-B3340B57-1418-487D-B2B2-6E2AA4C38F96 Q26777962-3988530C-07C8-4A71-BFFA-52244190DE24 Q27318048-13A92647-B17F-4955-B265-93D5B8C4C3E3 Q28068034-7924A3E5-E17D-47A5-817D-A4BA2378D9F0 Q28244342-A910DD09-CFDF-4010-A897-E16FF16300CD Q33554999-8439E4BB-0340-464C-8EC9-4933AE913AD8 Q33564220-914B71AA-A74A-41DB-8F88-6617D7718C9B Q34023157-B1400098-8492-4974-98EE-6DE4437E6F9F Q34520504-D304E2BB-0766-4516-AC92-B6AF2C84F941 Q34681621-FF9A56E4-24D0-409E-ADFF-59173469A673 Q34880903-BB3B0D78-00EA-45A8-827A-0D39C6CE68BD Q34994430-C6B4AF5D-E5E1-41A0-9082-DE837F26F758 Q35049028-4C31B428-06D5-4342-AC33-577B42DF46EE Q35128695-2346C474-711C-466C-89F9-FDD99E1950BA Q35223987-1360D3F5-C28E-426E-8800-78CFE2D75D1B Q35739702-0A7F6D95-94D5-4B54-9698-C6F091263FA7 Q35964567-0A602F53-AF09-4BED-A30B-1FA06FB8C486 Q36795260-0CB2D0E6-1632-4CA9-B57C-AFA92ED7B458 Q37076096-8DDC579C-7351-4000-8EE5-23D2B05184DC Q37140393-6E0E59BC-DE15-4565-A975-370B3E7FDA69 Q37709194-B0295952-E4F8-4050-B190-F942DDB3AED2 Q37960096-563108C9-CC3F-487A-A859-3ABDEFCDC198 Q38052031-19742962-11B0-425B-A5D3-4A8B3AB093CA Q38065902-F1952AFD-1DED-4F42-9BF7-18DEA033AEFC Q38100987-3EBADC3D-6001-4B1F-8A4D-4CCF90F16139 Q38596709-70053EBB-587F-47E0-8E61-093B727E90D5 Q39322768-91CDE5BB-2181-4311-8C93-27B94AF1A5D4 Q41717334-F3371A8E-4D32-4401-9269-7A5A449141DE Q42664511-DA03C3A0-ADC4-4545-97B6-06E41E277F6C Q45150879-59A56C01-530A-47B3-9BE8-E3925A7399FA Q47629413-ED0BBED6-84AE-4743-A81F-1043A52F3A29 Q47688387-5C08632E-BAE8-4A33-AB94-F619CE744AD6 Q49544329-1E431024-4321-4953-B78E-3B51C77FB128 Q51504349-8A5A3D16-5BA6-455F-B2FE-52B1E98412E8 Q51581859-C3C95BA0-5481-4459-B841-8FF5C6BACADC Q55066654-B02B8A45-15BF-4520-B04C-A49E027B7310 Q57044763-F93D9064-0AEC-4EC6-9E93-110A5AC78CA3 Q57492462-C4BAA23E-DC86-4B92-B7DA-E660735C87BA

P2860

Myostatin activation in patients with advanced heart failure and after mechanical unloading.

http://www.wikidata.org/entity/Q33803837

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Myostatin activation in patien ...... nd after mechanical unloading.

@ast

Myostatin activation in patien ...... nd after mechanical unloading.

@en

type

label

Myostatin activation in patien ...... nd after mechanical unloading.

@ast

Myostatin activation in patien ...... nd after mechanical unloading.

@en

prefLabel

Myostatin activation in patien ...... nd after mechanical unloading.

@ast

Myostatin activation in patien ...... nd after mechanical unloading.

@en

P1433

Q33803837-78A6A5E8-D286-4214-BF4E-5D628A053AB9

P1476

Q33803837-FE97B6C7-102A-4AC5-995F-20DB826F7451

P2093

Q33803837-27B0DBA7-4401-4428-B352-D0A90DB560F9

Q33803837-2FE0C578-B5B0-4EB9-B9AB-89DD9BC9BE5A

Q33803837-6BE66719-20B7-4763-8F84-3549B47AE72B

Q33803837-8A9DBE16-8131-4C60-910F-EBDC42588923

Q33803837-91F6B9DA-5437-4A05-9F4E-22F04EDE4102

Q33803837-C924B060-C720-4304-821E-C02C294D5FC5

Q33803837-FC640B38-3A2F-4EEE-ADFB-B24F6732FAD9

P2860

Q33803837-09F8970B-65C6-4D82-BC07-83BC8B8658B7

Q33803837-0C6F0B01-1360-4579-889C-B680F67A64F9

Q33803837-13F17BD9-C12C-4BAE-A253-78CF4F78E3FA

Q33803837-3D091B71-2A2E-4AC4-BEB3-2339E4AB0664

Q33803837-47D5AF0A-49B1-4D12-BF6B-E5A7110A370C

Q33803837-51C2994A-5AF7-4702-AFD2-FCDECF28DE30

Q33803837-5BC07910-39D7-402B-B682-EC0D64410665

Q33803837-69EB17A1-0336-4603-A056-F810567E41DF

Q33803837-78ED98B6-A3BD-4B70-AEAA-6F09F4653335

Q33803837-803BDDBC-A0FB-4936-A8B8-8AB56712FFE3

P304

Q33803837-E090B190-A1BA-4A02-A25F-68F57929ACD5

P31

Q33803837-2F8D49EC-79D7-4661-8208-172E381BB592

P356

Q33803837-8271AE6B-0682-4460-BA04-B35FACAECEE2

P433

Q33803837-E52B27A2-93FE-4F16-BFF3-AA4AB8BBEE20

P478

Q33803837-67784C82-9ACB-4828-ABFC-36B75C5471C4

P50

Q33803837-EEA5435E-B29B-40A4-8EBB-B7F9410FED5F

P577

Q33803837-40261F79-6672-4AAE-91D0-78D3D23B8373

P5875

Q33803837-D9B1B936-9270-4243-91DF-327397832A73

P698

Q33803837-1DDB2072-37A1-4D6C-B9C6-87C6C8B28002

P921

Q33803837-0883FB6D-6AD0-465F-B618-7E8E9A2F116F

P932

Q33803837-A91509E8-5903-426A-8F82-2272456A2EBC

P356

P1433

European Journal of Heart Failure

P1476

Myostatin activation in patien ...... and after mechanical unloading

@en

P2093

Gayathri Kamalakkannan

http://www.w3.org/2001/XMLSchema#string

H Lee Sweeney

http://www.w3.org/2001/XMLSchema#string

Isaac George

http://www.w3.org/2001/XMLSchema#string

Lawrence T Bish

http://www.w3.org/2001/XMLSchema#string

Mehmet C Oz

http://www.w3.org/2001/XMLSchema#string

Simon Maybaum

http://www.w3.org/2001/XMLSchema#string

Yoshifumi Naka

http://www.w3.org/2001/XMLSchema#string

P2860

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting

Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis

Regulation of myostatin activity and muscle growth

Myostatin regulates cardiomyocyte growth through modulation of Akt signaling

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

Left ventricular assist device and drug therapy for the reversal of heart failure

Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.

PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury

Induction of cachexia in mice by systemically administered myostatin.

Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes.

P304

444-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURJHF/HFQ039

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Petrilli

P577

2010-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42611243

http://www.w3.org/2001/XMLSchema#string

P698

20348550

http://www.w3.org/2001/XMLSchema#string

P921

P932

2857990

http://www.w3.org/2001/XMLSchema#string